SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Neuland Laboratories informs about newspaper publication

18 Apr 2018 Evaluate

Neuland Laboratories has informed about copies of newspaper publication on April 18, 2018, of the Notice of the Extra Ordinary General meeting scheduled to be held on Friday, May 11, 2018, published in Financial Express and Andhra Prabha, for the approval of the special business as set out in the Notice of the EGM.

The above information is a part of company’s filings submitted to BSE.

Neuland Laboratories Share Price

17693.65 393.20 (2.27%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×